Search results
Pfizer Offers up to $250 Million to Settle Thousands of Zantac Cancer Lawsuits, FT Reports
US News & World Report· 9 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
Guru Focus· 6 days agoStrengths highlight Pfizer's robust product portfolio and global market presence.Weaknesses underscore the challenges in revenue fluctuations and patent expira
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 3 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 8 hours agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 3 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks via Yahoo Finance· 3 days agoStocks recently featured in the blog include: Amazon.com, Inc. AMZN, Visa Inc. V, Pfizer Inc. PFE,...
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 1 day agoWall Street's consensus calls for Okta's earnings per share (EPS) to more than triple to $5.20 over the next four years. Image source: Getty Images. ...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 3 days agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...